Kangyuan Pharmaceutical (600557.SH) released its first quarter results, with a net profit attributable to shareholders of 83.413 million yuan, a year-on-year decrease of 38.37%.

Wisdom Finance and Economics APP News, Kangyuan Pharmaceutical (600557.SH) released the first quarter report of 2025, with the company's first quarter operating income of 878 million yuan, a year-on-year decrease of 35.38%; net profit attributable to shareholders of the listed company was 83.413 million yuan, a year-on-year decrease of 38.37%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 81.989 million yuan, a year-on-year decrease of 41.28%; basic earnings per share was 0.15 yuan/share.